Search results for

Charles de Ledesma reviews a new compact disk called, "Duality," by Lisa Gerrard (jair-ARD) and Peter Bourke. Gerrard comes from the band Dead Can Dance and Bourke is from Soma. "Duality" combines traditional rhythms with modern electronic sounds. "Duality" is in stores now on the 4AD label.

Nadine Seiler, one of those who watched over a fence at what became Black Lives Matter Plaza, is working to find homes for more than 700 artifacts that once covered the structure near the White House.

The pandemic has intensified burnout among health care workers. They say it's eroding their passion for the job and the quality of patient care. Here's how some of them are trying to solve it.

By nature and necessity, the Houma people are a sprawling but tight-knit community in the bayou region. Federal recognition for the tribe could keep them out of harm's way.

For many Haitian migrants, the dangerous journey from their troubled home country to the United States spans a decade and thousands of miles through Latin America.

In the vaccine era, people are wondering if it's (relatively) safe to resume hugs, exchange handshakes, kiss on the cheek or air-kiss.

The Occupational Safety and Health Administration doesn't have a heat standard to enforce, but it does make some recommendations to employers in high-risk industries.

A man "wearing full ninja garb" staged the attack in the middle of the night at a small airport in California, officials say.

U.S. journalist Danny Fenster remains in Myanmar's most infamous prison months after the Feb. 1 coup that restored the military to power and a spurred crackdown on dissent.

We remember Clifford Feldman, a former TV news producer who lived in Washington, D.C. Feldman was one of the nearly 700,000 Americans who have died from COVID.

NPR's Leila Fadel talks with Meg Linehan of The Athletic about her investigation into former National Women's Soccer League coach Paul Riley, who has been accused to sexual coercion.

Pharmaceutical giant Merck announced promising results from a study of a new antiviral drug. Molnupiravir reduced COVID hospitalizations or death by 50% in a trial involving 775 volunteers.